Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
VANCOUVER, British Columbia, Dec. 8, 2015 (GLOBE NEWSWIRE) -- Response Biomedical Corp. ("Response" or ...
Adds 177Lu-PSMA-617, a potential first-in-class radioligand therapy in Phase III development for metastatic castration-resistant ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email